BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 15768032)

  • 21. Wnt signaling is required for thymocyte development and activates Tcf-1 mediated transcription.
    Staal FJ; Meeldijk J; Moerer P; Jay P; van de Weerdt BC; Vainio S; Nolan GP; Clevers H
    Eur J Immunol; 2001 Jan; 31(1):285-93. PubMed ID: 11265645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coordinated expression of cyclin D1 and LEF-1/TCF transcription factor is restricted to a subset of hepatocellular carcinoma.
    Schmitt-Graeff A; Ertelt-Heitzmann V; Allgaier HP; Olschewski M; Nitschke R; Haxelmans S; Koelble K; Behrens J; Blum HE
    Liver Int; 2005 Aug; 25(4):839-47. PubMed ID: 15998435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A common human skin tumour is caused by activating mutations in beta-catenin.
    Chan EF; Gat U; McNiff JM; Fuchs E
    Nat Genet; 1999 Apr; 21(4):410-3. PubMed ID: 10192393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIC1 attenuates Wnt signaling by recruitment of TCF-4 and beta-catenin to the nuclear bodies.
    Valenta T; Lukas J; Doubravska L; Fafilek B; Korinek V
    EMBO J; 2006 Jun; 25(11):2326-37. PubMed ID: 16724116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Wnt-3a regulates chondrocyte differentiation via c-Jun/AP-1 pathway.
    Hwang SG; Yu SS; Lee SW; Chun JS
    FEBS Lett; 2005 Aug; 579(21):4837-42. PubMed ID: 16099458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HMG box transcription factor TCF-4's interaction with CtBP1 controls the expression of the Wnt target Axin2/Conductin in human embryonic kidney cells.
    Valenta T; Lukas J; Korinek V
    Nucleic Acids Res; 2003 May; 31(9):2369-80. PubMed ID: 12711682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta-catenin/T-cell factor-mediated transcription is modulated by cell density in human bronchial epithelial cells.
    Steel MD; Puddicombe SM; Hamilton LM; Powell RM; Holloway JW; Holgate ST; Davies DE; Collins JE
    Int J Biochem Cell Biol; 2005 Jun; 37(6):1281-95. PubMed ID: 15778091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction and functional cooperation between the LIM protein FHL2, CBP/p300, and beta-catenin.
    Labalette C; Renard CA; Neuveut C; Buendia MA; Wei Y
    Mol Cell Biol; 2004 Dec; 24(24):10689-702. PubMed ID: 15572674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transactivation of vimentin by beta-catenin in human breast cancer cells.
    Gilles C; Polette M; Mestdagt M; Nawrocki-Raby B; Ruggeri P; Birembaut P; Foidart JM
    Cancer Res; 2003 May; 63(10):2658-64. PubMed ID: 12750294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential formation of beta-catenin/lymphoid enhancer factor-1 DNA binding complex induced by nitric oxide in mouse colonic epithelial cells differing in adenomatous polyposis coli (Apc) genotype.
    Mei JM; Hord NG; Winterstein DF; Donald SP; Phang JM
    Cancer Res; 2000 Jul; 60(13):3379-83. PubMed ID: 10910042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mapping canonical Wnt signaling in the developing and adult retina.
    Liu H; Thurig S; Mohamed O; Dufort D; Wallace VA
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):5088-97. PubMed ID: 17065530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. "Decisions, decisions.": beta-catenin-mediated activation of TCF-1 and Lef-1 influences the fate of developing T cells.
    Wu L; Strasser A
    Nat Immunol; 2001 Sep; 2(9):823-4. PubMed ID: 11526393
    [No Abstract]   [Full Text] [Related]  

  • 33. TGF-beta induces novel Lef-1 splice variants through a Smad-independent signaling pathway.
    Cordray P; Satterwhite DJ
    Dev Dyn; 2005 Apr; 232(4):969-78. PubMed ID: 15736165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta-catenin-related anomalies in apoptosis-resistant and hormone-refractory prostate cancer cells.
    de la Taille A; Rubin MA; Chen MW; Vacherot F; de Medina SG; Burchardt M; Buttyan R; Chopin D
    Clin Cancer Res; 2003 May; 9(5):1801-7. PubMed ID: 12738737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Galectin-3, a novel binding partner of beta-catenin.
    Shimura T; Takenaka Y; Tsutsumi S; Hogan V; Kikuchi A; Raz A
    Cancer Res; 2004 Sep; 64(18):6363-7. PubMed ID: 15374939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mastermind-like 1 Is a specific coactivator of beta-catenin transcription activation and is essential for colon carcinoma cell survival.
    Alves-Guerra MC; Ronchini C; Capobianco AJ
    Cancer Res; 2007 Sep; 67(18):8690-8. PubMed ID: 17875709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A beta-catenin identified by functional rather than sequence criteria and its role in Wnt/MAPK signaling.
    Kidd AR; Miskowski JA; Siegfried KR; Sawa H; Kimble J
    Cell; 2005 Jun; 121(5):761-72. PubMed ID: 15935762
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors.
    Levanon D; Goldstein RE; Bernstein Y; Tang H; Goldenberg D; Stifani S; Paroush Z; Groner Y
    Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11590-5. PubMed ID: 9751710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Failure of a medulloblastoma-derived mutant of SUFU to suppress WNT signaling.
    Taylor MD; Zhang X; Liu L; Hui CC; Mainprize TG; Scherer SW; Wainwright B; Hogg D; Rutka JT
    Oncogene; 2004 Jun; 23(26):4577-83. PubMed ID: 15077159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Signaling through beta-catenin and Lef/Tcf.
    Novak A; Dedhar S
    Cell Mol Life Sci; 1999 Oct; 56(5-6):523-37. PubMed ID: 11212302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.